Explore the CGT Car-T Cell Therapy Pipeline with Miltenyi Services
T&L Biotechnology Co., Ltd. is at the forefront of developing innovative Cell Therapy products, with a specific focus on Car-T Cell Therapy. Our pipeline includes several promising products that have the potential to revolutionize cancer treatment, One of our lead candidates is our Car-T Cell Therapy, which involves genetically modifying a patient's own T-cells to target and destroy cancer cells. This personalized approach has shown remarkable results in clinical trials, with many patients experiencing complete remission and prolonged survival, At T&L Biotechnology Co., Ltd., we believe that Car-T Cell Therapy has the potential to change the landscape of cancer treatment, and we are proud to be at the forefront of this exciting field. We are dedicated to bringing innovative and life-saving therapies to the market, with a mission to improve patient outcomes and quality of life
- Cell therapy Tcr-Engineered T Cells
- Custom Bispecific T-Cell Engagers (Bites)
- High-Quality Bispecific T-Cell Engagers (Bites)
- CGT Bispecific T-Cell Engagers (Bites)
- Cell therapy Bispecific T-Cell Engagers (Bites)
- Custom Natural Killer Cell Therapies
- High-Quality Natural Killer Cell Therapies
- CGT Natural Killer Cell Therapies
- Cell therapy Natural Killer Cell Therapies
- Custom Regulatory T-Cell Therapy